MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$66,539K
Net loss
-$66,539K
(-1005.30%↓ Y/Y)
Other income, net
$8,801K
(97.20%↑ Y/Y)
Interest income
$2,216K
(-56.73%↓ Y/Y)
Sales Channel
Directly To Consumer
$146,668K
(-2.14%↓ Y/Y)
Sales Channel Through
Intermediary
$54,825K
(8.39%↑ Y/Y)
Provision for (benefit
from) income taxes
$36,698K
(11368.13%↑ Y/Y)
Loss before income
taxes
-$29,841K
(-423.53%↓ Y/Y)
Total other income,
net
$10,543K
(-28.87%↓ Y/Y)
Total revenue, net
$201,493K
(0.52%↑ Y/Y)
Interest income
(expense), net (notes 11,...
$474K
(109.05%↑ Y/Y)
Loss from operations
-$40,384K
(-96.77%↓ Y/Y)
Gross profit
$104,460K
(-5.98%↓ Y/Y)
Total cost of sales
$97,033K
(8.60%↑ Y/Y)
Total operating
expenses
$144,844K
(10.04%↑ Y/Y)
General and
administrative
$58,936K
(36.70%↑ Y/Y)
Sales and marketing
$49,440K
(0.66%↑ Y/Y)
Research and development
$36,468K
(-7.45%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)